SCHEMBL8457459

SCHEMBL8457459

CCc1ccc(COC2CCCCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 9/20 0.46
PRMT6 Q96LA8 9/20 0.46
OPRM1 P35372 2/20 0.41
OPRL1 P41146 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NAAA Q02083 2/20 0.40
GRM5 P41594 1/20 0.39
TMEM97 Q5BJF2 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
PRMT8 Q9NR22 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
SLC6A2 P23975 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR7 P34969 1/20 0.38
HTR2B P41595 1/20 0.38
HTR3A P46098 1/20 0.38
SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18615720 0.98 CARM1 (0.43) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL18611721 0.93 CARM1 (0.46) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL4962479 0.90 CARM1 (0.48) CARM1PRMT6OPRM1OPRL1NAAA
SCHEMBL11587452 0.85 NAAA (0.54) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL1837908 0.82 NPC1 (0.46) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL18615830 0.82 NAAA (0.51) CARM1PRMT6OPRM1OPRL1NAAA
SCHEMBL1837027 0.82 NPC1 (0.46) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL1836248 0.82 NPC1 (0.46) CARM1PRMT6OPRM1OPRL1NPC1
SCHEMBL14394540 0.82 SMN1; SMN2 (0.43) CARM1PRMT6OPRM1OPRL1NAAA
SCHEMBL22454181 0.81 NAAA (0.56) CARM1PRMT6NPC1RAB9ANAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058380-A1 ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE SANOFI-AVENTIS (FR) 2008-03-06 US disclosed
US-7288659-B2 Acylaminothiazole derivatives, their preparation and therapeutic use SANOFI-AVENTIS (FR) 2007-10-30 US disclosed
US-5976408-A Acrylonitrile derivative, liquid crystal composition, and liquid crystal display device CHISSO CORPORATION (JP) 1999-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058380-A1 ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE PARK7, ACAT1, APP CARM1 1092/4885PRMT6 227/4885OPRM1 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.